Skip to main content

Practice areas


  1. Intellectual Property: 75%
    18 years
  2. Patent Application: 25%
    18 years, 400 cases

Attorney endorsements

No endorsements

Endorsements from fellow lawyers are an important consideration for many when selecting the right attorney. Be the first to endorse your colleague!

Are you an attorney? Endorse this lawyer

Contact info

Seed Intellectual Property Law Group PLLC

701 Fifth Avenue Suite 5400
Seattle, WA, 98104


We have not found any instances of professional misconduct for this lawyer.
Avvo contributions
Legal answers
Award nameGrantorDate granted
2010 Best Lawyers in AmericaBest Lawyers in America2009
2009 Super LawyerWashington Law & Politics Magazine2009
2008 Washington Super LawyerWashington Law & Politics Magazine2008
2007 Washington Super LawyerN/A2007
2006 Washington Super LawyerN/A2006
2005 Washington Super LawyerN/A2005
2003 Washington Super LawyerN/A2003
2002 Washington Super LawyerN/A2002
Rising StarN/A2001
Rohm and Haas Outstanding Graduate StudentN/A1995
Graduate School Award in ScienceN/A1995
American Heart Association FellowshipN/A1995
American Heart Association FellowshipN/A1994
Work experience
TitleCompany nameDuration
Legal InternAttorney General's Office1996 - 1996
Association namePosition nameDuration
Washington Biotechnology and Biomedical AssociationMember2000 - Present
Washington State Bar AssociationMember1998 - Present
American Bar AssociationMember1998 - Present
American Intellectual Property Law AssociationMember1998 - Present
Pacific Rim Law and Policy JournalArticles Editor1996 - 1998
Publication nameTitleDate
CASRIP SYMPOSIUM SERIESThe Experimental Use Exception and the Pharmaceutical Industry2002
UnknownFinancing the High-Tech Business2002
UnknownBusiness Aspects of High-Tech Business2002
National Paralegal ReporterSteps to Take and Issues to Consider Prior to Filing a Patent Application1998
AIPPIJapanese Publication of Patent Term Extension of Pharmaceuticals in Japan1997
Pacific Rim Law & Policy JournalPatent Term Extension of Pharmaceuticals in Japan1997
UnknownThe Hydrophobic Nature of Residue-5 of Human Protein C is a Major Determinant of its Functional Interactions with Acidic Phospholipid Vesicles1996
UnknownHydrophobic Amino Acid Residues of Human Anticoagulation Protein C that Contribute to its Functional Binding to Phospholipid Vesicles1995
UnknownStructure-Function Assessment of the Role of the Helical Stack Domain in the Properties of Human Recombinant Protein C and Activated Protein C1995
UnknownTransport of Specific Endothelial Cell Binding Properties from the Procoagulant Protein, Human Factor IX, into the Anticoagulant Protein, Human Protein C1995
UnknownFunctions of Individual gamma-Carboxyglutamic Acid Residues of Human Protein C. Determination of Functionally Nonessential Gla Residues and Correlations with their Mode of Binding to Calcium1994
UnknownProperties of Recombinant Chimeric Human Protein C and Activated Protein C Containing the gamma-Carboxyglutamic Acid and Trailing Helical Stack Domains of Protein C Replaced by Those of Human Coagulation Factor IX1994
UnknownThe Activities of Recombinant gamma-Carboxyglutamic-Acid-Deficient Mutants of Activated Human Protein C Toward Human Coagulation Factor Va and Factor VIII in Purified Systems and in Plasma1994
UnknownConstruction, Expression, and Properties of a Recombinant Chimeric Human Protein C with Replacement of Its Growth Factor-like Domains by Those of Human Coagulation Factor IX1994
School nameMajorDegreeGraduated
University of Washington School of LawLawJD - Juris Doctor1998
University of Notre DameBiochemistry, Biophysics, and Molecular BiologyPhD - Doctorate1995
Oregon State UniversityBiochemistry and BiophysicsBS - Bachelor of Science1991
Speaking engagements
Conference nameTitleDate
2009 IPTA Annual ConferencePatentable Subject Matter2009
Molecular Medicine Tri-ConferencePatent law related to Stem Cells2008
LSI's Biotechnology ConferenceRecent Federal Circuit Opinions Affecting Biotech Companies2007
Critical Patent Strategies for US FilingsPriority dates and filing strategies for life sciences2007
BiotechnologyPatent Rules to Live and Die By2005
AusBiotech2004Recent Trends at the USPTO2004
CASRIP SymposiumThe Experimental Use Exception and the Pharmaceutical Industry2002
Biotechnology from Start to FinishPatent Basics2002
International Conference on Generic DrugsExperimental Use Exception to Infringement2001
CBI's Forum on International Generic DrugsOvercome Barriers to Market Entry for Generics in Europe and Japan2000
XVth International Congress on Thrombosis and HaemostasisBovine Aortic Endothelial Cell Binding Studies of Chimeric Recombinant Protein C Molecules and Their Effectiveness as Potential Anticoagulants1995